AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14977342 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol for induction and sevoflurane for maintenance (Group P/S)
Number of subjects: 96
Study 14977342 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (Group S)
Number of subjects: 96
Study 14588230 — intervention group
Group type: EXPERIMENTAL
Intervention: OCD patients
Number of subjects: 30
Study 14588230 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 10559610 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical nephrectomy with complete lymph node dissection
Number of subjects: 772
Study 10559610 — intervention group
Group type: COMPARATOR
Intervention: Radical nephrectomy alone
Number of subjects: 772
Study 10559610 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete lymph node dissection
Number of subjects: 772
Study 7774535 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolled oats (muesli)
Number of subjects: 9
Study 7774535 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled rolled oats (oat porridge)
Number of subjects: 9
Study 7774535 — intervention group
Group type: COMPARATOR
Intervention: White wheat bread
Number of subjects: 9
Study 7774535 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled intact oat kernels (kernel porridge)
Number of subjects: 9
Study 7774535 — intervention group
Group type: EXPERIMENTAL
Intervention: Boiled intact wheat kernels (kernel porridge)
Number of subjects: 9
Study 2183873 — intervention group
Group type: EXPERIMENTAL
Intervention: Didox 6 g m‐2 by 36 h infusion
Number of subjects: 12
Study 2183873 — intervention group
Group type: COMPARATOR
Intervention: Didox 6 g m‐2 by 30 min infusion
Number of subjects: 12
Study 7463326 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of dexamethasone at 11 pm (Treatment A)
Number of subjects: 9
Study 7463326 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of dexamethasone at 11 pm (Treatment B)
Number of subjects: 9
Study 7463326 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of dexamethasone at 11 pm and an additional 1 mg at 6 am (Treatment C)
Number of subjects: 9
Study 29170998 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic maintenance fluid (NaCl 0.9% in glucose 5% with 40 mmol L‐1 potassium chloride)
Number of subjects: 68
Study 29170998 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic maintenance fluid (premixed solution containing 54 mmol L‐1 sodium, 55 mmol L‐1 chloride and 26 mmol of potassium)
Number of subjects: 68
Study 25701156 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified informed consent form (features include plain language, short sentences, diagrams, pictures, and bullet points)
Number of subjects: 150
Study 25701156 — intervention group
Group type: COMPARATOR
Intervention: Standard informed consent form
Number of subjects: 150
Study 23816316 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention group
Number of subjects: 0
Study 23816316 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study 22068990 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (EC-IC bypass surgery)
Number of subjects: 195
Study 22068990 — intervention group
Group type: COMPARATOR
Intervention: No surgery (best medical therapy)
Number of subjects: 195
Study 19360858 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 2381
Study 19360858 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 2381
Study 16905810 — intervention group
Group type: EXPERIMENTAL
Intervention: Curiosin and plasma-therapy
Number of subjects: 130
Study 16905810 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment (control group)
Number of subjects: 130
Study 15688984 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) treatment at a dose of 4 g/day i.v. for the first 24 hours after admission
Number of subjects: 0
Study 15688984 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without MgSO4
Number of subjects: 0
Study 11343038 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous secretin (2.0 clinical units per kg as a single dose)
Number of subjects: 60
Study 11343038 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 60
Study 9389261 — intervention group
Group type: EXPERIMENTAL
Intervention: suxamethonium 1.0 mg kg-1
Number of subjects: 120
Study 9389261 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.9 mg kg-1
Number of subjects: 120
Study 9389261 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium 0.1 mg kg-1 with rocuronium 0.3 mg kg-1
Number of subjects: 120
Study 9389261 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium 0.15 mg kg-1 with rocuronium 0.45 mg kg-1
Number of subjects: 120
Study 9389261 — intervention group
Group type: COMPARATOR
Intervention: mivacurium 0.2 mg kg-1
Number of subjects: 120
Study 9389261 — intervention group
Group type: COMPARATOR
Intervention: rocuronium 0.6 mg kg-1
Number of subjects: 120
Study 9389261 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.45 mg kg-1 and mivacurium 0.15 mg kg-1
Number of subjects: 120
Study 7893583 — intervention group
Group type: EXPERIMENTAL
Intervention: Idrapril calcium 100 mg twice daily
Number of subjects: 0
Study 7893583 — intervention group
Group type: EXPERIMENTAL
Intervention: Idrapril calcium 200 mg twice daily
Number of subjects: 0
Study 7893583 — intervention group
Group type: EXPERIMENTAL
Intervention: Idrapril calcium 400 mg twice daily
Number of subjects: 0
Study 7893583 — intervention group
Group type: EXPERIMENTAL
Intervention: Idrapril calcium (all doses)
Number of subjects: 0
Study 7893583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30348220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastery Approach to Coaching (MAC) program
Number of subjects: 293
Study 30348220 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MAC program)
Number of subjects: 293
Study 27513402 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT)
Number of subjects: 0
Study 27513402 — intervention group
Group type: COMPARATOR
Intervention: Placebo Kinesiotaping (KT)
Number of subjects: 0
Study 27513402 — intervention group
Group type: COMPARATOR
Intervention: Orthotic Device (OD)
Number of subjects: 0
Study 24508475 — intervention group
Group type: EXPERIMENTAL
Intervention: Early dialysis initiation (eGFR at initiation ≥10mL/min/1.73m(2))
Number of subjects: 652
Study 24508475 — intervention group
Group type: COMPARATOR
Intervention: Later dialysis initiation (eGFR < 10mL/min/1.73m(2))
Number of subjects: 652
Study 22591121 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 343
Study 22591121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study 22591121 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 343
Study 21054991 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ ReSTOR IOL (SN6AD3)
Number of subjects: 50
Study 21054991 — intervention group
Group type: COMPARATOR
Intervention: AcrySof IQ IOL (SN60WF)
Number of subjects: 50
Study 17906871 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg) plus visual sexual stimulation (VSS)
Number of subjects: 11
Study 17906871 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus visual sexual stimulation (VSS)
Number of subjects: 11
Study 16827862 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac/Mycophenolate Mofetil (MMF)
Number of subjects: 82
Study 16827862 — intervention group
Group type: COMPARATOR
Intervention: Tac/Sirolimus (SRL)
Number of subjects: 82
Study 12839049 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (streptokinase or rt-PA)
Number of subjects: 60
Study 12839049 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 60
Study 12839049 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis (TIMI flow 0/1)
Number of subjects: 60
Study 12839049 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal values)
Number of subjects: 60
Study 10638606 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 2.0 mg i.v. over 3-5 min
Number of subjects: 20
Study 10638606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10638606 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (open-label treatment)
Number of subjects: 20
Study 10638606 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 20
Study 8800029 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion achieved by 60 minutes (group M1)
Number of subjects: 36
Study 8800029 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion achieved by 130 minutes (group M2)
Number of subjects: 36
Study 8800029 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M1 (Reperfusion at 60 minutes)
Number of subjects: 36
Study 8800029 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M2 (Reperfusion at 130 minutes)
Number of subjects: 36
Study 8800029 — intervention group
Group type: COMPARATOR
Intervention: Both groups (M1 and M2)
Number of subjects: 36
Study 1473540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime + Ampicillin (CAZ + AMP)
Number of subjects: 1316
Study 1473540 — intervention group
Group type: COMPARATOR
Intervention: Aminoglycoside + Ampicillin (AG + AMP)
Number of subjects: 1316
Study 1473540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime monotherapy (CAZ)
Number of subjects: 1316
Study 1473540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime or Ceftazidime + Ampicillin (CAZ or CAZ + AMP)
Number of subjects: 1316
Study 1473540 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1316
Study 6464961 — intervention group
Group type: EXPERIMENTAL
Intervention: Group type A behavior counseling in addition to group cardiologic counseling
Number of subjects: 862
Study 6464961 — intervention group
Group type: COMPARATOR
Intervention: Group cardiologic counseling
Number of subjects: 862
Study 31251546 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 210
Study 31251546 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% cream
Number of subjects: 210
Study 31251546 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 210
Study 30052230 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled levosimendan administered 6th hourly over 24 h
Number of subjects: 50
Study 30052230 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous levosimendan infusion at 0.1 mcg/kg/min for 24 h
Number of subjects: 50
Study 30052230 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as the comparison between inhaled and intravenous levosimendan)
Number of subjects: 50
Study 27352492 — intervention group
Group type: EXPERIMENTAL
Intervention: SHI's manipulation
Number of subjects: 108
Study 27352492 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 108
Study 27352492 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 108
Study 24560584 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbiotic Drink (administered via enteral feeding during the first 7 days)
Number of subjects: 89
Study 24560584 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 89
Study 23189108 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Students in the Hospital program)
Number of subjects: 760
Study 23189108 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 760
Study 19281535 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 45
Study 19281535 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemofiltration
Number of subjects: 45
Study 19281535 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 17588310 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency sensory nerve stimulation (LF‐SNS) for 12 weeks
Number of subjects: 66
Study 17588310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 17588310 — intervention group
Group type: EXPERIMENTAL
Intervention: LF‐SNS in responders
Number of subjects: 66
Study 16376754 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed-wave tissue Doppler (PW-TD) method
Number of subjects: 120
Study 16376754 — intervention group
Group type: COMPARATOR
Intervention: Conventional pulsed-wave Doppler (PWD) method
Number of subjects: 120
Study 16376754 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (PW-TD and PWD)
Number of subjects: 120
Study 12271103 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of pets
Number of subjects: 240
Study 12271103 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of spouse
Number of subjects: 240
Study 12271103 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of friend (for non-pet owners)
Number of subjects: 240
Study 12271103 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of spouse and pet/friend
Number of subjects: 240
Study 9814627 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril/hydrochlorothiazide (20/6 mg) daily
Number of subjects: 174
Study 9814627 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 mg) daily
Number of subjects: 174
Study 8593194 — intervention group
Group type: EXPERIMENTAL
Intervention: stabilized 0.454% stannous fluoride dentifrice
Number of subjects: 328
Study 8593194 — intervention group
Group type: COMPARATOR
Intervention: 0.243% sodium fluoride control
Number of subjects: 328
Study 2503631 — intervention group
Group type: COMPARATOR
Intervention: Glucose infusion (N=13)
Number of subjects: 51
Study 2503631 — intervention group
Group type: COMPARATOR
Intervention: Lipid infusion (N=11)
Number of subjects: 51
Study 2503631 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid infusion (N=17)
Number of subjects: 51
Study 2503631 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) (N=10)
Number of subjects: 51
Study 797067 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon-arc photocoagulation treatment
Number of subjects: 100
Study 797067 — intervention group
Group type: COMPARATOR
Intervention: Untreated eyes
Number of subjects: 100
Study 797067 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated eyes
Number of subjects: 100
Study 31742849 — intervention group
Group type: EXPERIMENTAL
Intervention: MLAM-IV
Number of subjects: 120
Study 31742849 — intervention group
Group type: COMPARATOR
Intervention: LAM-IV
Number of subjects: 120
Study 31805902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1 (changes in school environment)
Number of subjects: 0
Study 31805902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 2 (changes in menu and school environment)
Number of subjects: 0
Study 31805902 — intervention group
Group type: COMPARATOR
Intervention: Control group (without intervention)
Number of subjects: 0
Study 31805902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1 and 2
Number of subjects: 0
Study 27790760 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (STR)
Number of subjects: 40
Study 27790760 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Training (CT)
Number of subjects: 40
Study 27790760 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor Hockey (HOC)
Number of subjects: 40
Study 27790760 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 40
Study 25959708 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL) using the GlideScope Cobalt AVL video laryngoscope
Number of subjects: 21
Study 25959708 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 21
Study 25959708 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 21
Study 23533022 — intervention group
Group type: EXPERIMENTAL
Intervention: Maps with varying attributes of a residential drinking water hazard (level, proximity, prevalence, density)
Number of subjects: 446
Study 23533022 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in the problem's seriousness
Number of subjects: 446
Study 23533022 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived susceptibility
Number of subjects: 446
Study 21346607 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐925 50 mg QD
Number of subjects: 155
Study 21346607 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐925 150 mg QD
Number of subjects: 155
Study 21346607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 19731780 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to 20 minutes of relaxing music
Number of subjects: 0
Study 19731780 — intervention group
Group type: COMPARATOR
Intervention: 20 minutes of bed rest
Number of subjects: 0
Study 17356091 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mug of salbutamol
Number of subjects: 120
Study 17356091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 17356091 — intervention group
Group type: COMPARATOR
Intervention: Control (no inhaled medication)
Number of subjects: 120
Study 15375224 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.2 mmol/kg)
Number of subjects: 47
Study 15375224 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 47
Study 11257264 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 356
Study 11257264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study 9589535 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone
Number of subjects: 40
Study 9589535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7981459 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mgs/day
Number of subjects: 2012
Study 7981459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2012
Study 2531065 — intervention group
Group type: EXPERIMENTAL
Intervention: methacholine
Number of subjects: 15
Study 2531065 — intervention group
Group type: EXPERIMENTAL
Intervention: histamine
Number of subjects: 15
Study 2531065 — intervention group
Group type: EXPERIMENTAL
Intervention: ipratropium bromide
Number of subjects: 15
Study 922328 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 IU vitamin D daily
Number of subjects: 0
Study 922328 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D daily
Number of subjects: 0
Study 922328 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30221338 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided IBPB (group U)
Number of subjects: 109
Study 30221338 — intervention group
Group type: EXPERIMENTAL
Intervention: PNS-confirmation IBPB (group N)
Number of subjects: 109
Study 30221338 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided, PNS-confirmed IBPB (dual guidance; group NU)
Number of subjects: 109
Study 30221338 — intervention group
Group type: EXPERIMENTAL
Intervention: PNS-guided IBPB (group N)
Number of subjects: 109
Study 26714522 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 169
Study 26714522 — intervention group
Group type: COMPARATOR
Intervention: Usual care (treatment-as-usual)
Number of subjects: 169
Study 24706191 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% poikilocapnic hypoxia
Number of subjects: 12
Study 24706191 — intervention group
Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 12
Study 22462372 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (17 Hz, at 1.1 m x s(‐2) in the z‐axis) for 15 min after 14 min of rest at each altitude
Number of subjects: 10
Study 22462372 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration
Number of subjects: 10
Study 22462372 — intervention group
Group type: EXPERIMENTAL
Intervention: Low vibration intensity used in the study
Number of subjects: 10
Study 19863739 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose rocuronium (0.45 mg x kg(‐1))
Number of subjects: 105
Study 19863739 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose rocuronium (0.6 mg.kg(‐1))
Number of subjects: 105
Study 19863739 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (0.1 mg x kg(‐1))
Number of subjects: 105
Study 19863739 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 105
Study 17564674 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) at 30 Hz; 3.5 g (1 g=9.81 m.s2)
Number of subjects: 7
Study 17564674 — intervention group
Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 7
Study 16282676 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxercalciferol at 35%, 50%, or 65% of paricalcitol dose for 6 weeks
Number of subjects: 27
Study 12242054 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg mifepristone
Number of subjects: 30
Study 12242054 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg and 1200 mg mifepristone
Number of subjects: 30
Study 10235156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy (50 Gy in 25 fractions over 5 weeks, plus cisplatin intravenously on the first day of weeks 1, 5, 8, and 11, and fluorouracil, 1 g/m2 per day by continuous infusion on the first 4 days of weeks 1, 5, 8, and 11)
Number of subjects: 196
Study 10235156 — intervention group
Group type: COMPARATOR
Intervention: RT only (64 Gy in 32 fractions over 6.4 weeks)
Number of subjects: 196
Study 10235156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy (in the nonrandomized part)
Number of subjects: 196
Study 10235156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy
Number of subjects: 196
Study 10235156 — intervention group
Group type: COMPARATOR
Intervention: Combined modality therapy and RT only
Number of subjects: 196
Study 8730980 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzhexol (5 mg)
Number of subjects: 10
Study 1959719 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport activity (for asthmatic children)
Number of subjects: 30
Study 1959719 — intervention group
Group type: COMPARATOR
Intervention: No sport activity (control group)
Number of subjects: 30